Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (121-130 of 280) with videos related to

Pageof 28
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 10, 2015
Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and TissuesAnniina Koski, Simona Bramante, Anja Kipar, et al.
Human Gene Therapy|August 14, 2023
Viral Vectors Expressing Interleukin 2 for Cancer ImmunotherapyHongbin Wang, Mia Borlongan, Akseli Hemminki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporterTanja Hakkarainen, Maria Rajecki, Mirkka Sarparanta, et al.
Plos One|March 24, 2015
Incomplete but infectious vaccinia virions are produced in the absence of oncolysis in feline SCCF1 cellsSuvi Parviainen, Karoliina Autio, Markus Vähä-Koskela, et al.
Cancer|September 2, 2006
Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancerMerja Sarkioja, Anna Kanerva, Jarmo Salo, et al.
Plos One|November 17, 2010
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirusLaura Ahtiainen, Cristina Mirantes, Tiina Jahkola, et al.
Journal of Translational Medicine|August 23, 2013
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatmentMari Hirvinen, Raita Heiskanen, Minna Oksanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 11, 2014
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumorsAnna Kanerva, Anniina Koski, Ilkka Liikanen, et al.
Cells|January 30, 2021
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1Riikka Havunen, Riikka Kalliokoski, Mikko Siurala, et al.
Molecular and Cellular Biochemistry|July 24, 2012
Deficiency of the complex I of the mitochondrial respiratory chain but improved adenylate control over succinate-dependent respiration are human gastric cancer-specific phenomenaMarju Puurand, Nadežda Peet, Andres Piirsoo, et al.
Pageof 28

Showing results (121-130 of 280) with videos related to

Sort By:
Pageof 28
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 10, 2015
Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and TissuesAnniina Koski, Simona Bramante, Anja Kipar, et al.
Human Gene Therapy|August 14, 2023
Viral Vectors Expressing Interleukin 2 for Cancer ImmunotherapyHongbin Wang, Mia Borlongan, Akseli Hemminki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporterTanja Hakkarainen, Maria Rajecki, Mirkka Sarparanta, et al.
Plos One|March 24, 2015
Incomplete but infectious vaccinia virions are produced in the absence of oncolysis in feline SCCF1 cellsSuvi Parviainen, Karoliina Autio, Markus Vähä-Koskela, et al.
Cancer|September 2, 2006
Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancerMerja Sarkioja, Anna Kanerva, Jarmo Salo, et al.
Plos One|November 17, 2010
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirusLaura Ahtiainen, Cristina Mirantes, Tiina Jahkola, et al.
Journal of Translational Medicine|August 23, 2013
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatmentMari Hirvinen, Raita Heiskanen, Minna Oksanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 11, 2014
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumorsAnna Kanerva, Anniina Koski, Ilkka Liikanen, et al.
Cells|January 30, 2021
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1Riikka Havunen, Riikka Kalliokoski, Mikko Siurala, et al.
Molecular and Cellular Biochemistry|July 24, 2012
Deficiency of the complex I of the mitochondrial respiratory chain but improved adenylate control over succinate-dependent respiration are human gastric cancer-specific phenomenaMarju Puurand, Nadežda Peet, Andres Piirsoo, et al.
Pageof 28